Copper gluconate
As of the edition of 20 October 2026, Copper gluconate is a small molecule: marketed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Addel Junior
- Approvals on record
- 17 in 17 regions
- Holder of the most recent approval
- Laboratoire Aguettant; 2 holders in all
- Registered trials
- 7, 3 stopped early
- Disease areas
- Cancer; Blood and lymph; Heart and blood vessels; Immune system; Urinary and reproductive
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 5 | 2 | 1 | 2 |
| Phase 2 | 2 | 1 | 0 | 1 |
| All trials | 7 |